Who founded SiVEC Biotechnologies?

SiVEC Biotechnologies was founded by Lyndsey Linke, PhD in 2022.

How much funding has SiVEC Biotechnologies raised?

SiVEC Biotechnologies has disclosed $3.3M raised across 1 round.

Where is SiVEC Biotechnologies headquartered?

SiVEC Biotechnologies is headquartered in Fort Collins, US.

SiVEC Biotechnologies

Fort Collins, US · Founded 2022 · Delaware corporation

Find your way into SiVEC Biotechnologies

126 people in our graph share verified history with the SiVEC Biotechnologies team — schools, employers, funds. One of them is your warm intro.

Tim Weelborgunlockedknows Darcy Mora · together at Colorado State University (overlapped)

×11knows the team · via Colorado State University

SiVEC Biotechnologies develops BactPac, a live biotherapeutic delivery platform that enables targeted delivery of nucleic acid therapies and gene editing therapies for clinical advancement. The company licenses its platform technology to pharmaceutical partners and pursues its own therapeutic pipeline in oncology and other disease areas.

Biotech Deep Tech Medical Devices

Founders & leadership

SiVEC Biotechnologies was founded in 2022 by Lyndsey Linke, PhD.

Lyndsey Linke, PhDCEO, Co-founder, and Chairman of the Board of Directors

Darcy Mora Vice President of OperationsDarcy Mora holds a Master of Science in Clinical Sciences with a focus on Veterinary Epidemiology and a Bachelor of Science in Biochemistry from Colorado State University; she has worked in research since 2007 across assay development, molecular cloning, animal models, vaccine development, and virology, and serves as VP of Operations and Co-founder of SiVEC Biotechnologies, which develops BactPac, a bacterial-based delivery platform for nucleic acid and gene therapies.

Lyndsey LinkeNamed on SEC filing

Sibylle HauserNamed on SEC filing

Board

Richard A. Freed IIIBoard director

David SherrisBoard director

Reported raises · per SEC filings

Form D private placements

$3.3M disclosed across 1 round · 2025

▶$3.3MraisedSep 2025 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

David SherrisDirector
Darcy MoraExecutive Officer, Director
Lyndsey LinkeExecutive Officer, Director
Richard A. Freed IIIDirector
Sibylle HauserDirector

Offering amount: $5.8M
Amount sold: $3.3M
First sale: Aug 2025
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2021	$286.1K
National Institutes of Health (NIH)National Institutes of Health	Phase II	2020	$3M
National Institutes of Health (NIH)National Institutes of Health	Phase I	2018	$293.1K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does SiVEC Biotechnologies do?: SiVEC Biotechnologies develops BactPac, a live biotherapeutic delivery platform that enables targeted delivery of nucleic acid therapies and gene editing therapies for clinical advancement. The company licenses its platform technology to pharmaceutical partners and pursues its own therapeutic pipeline in oncology and other disease areas.
Who founded SiVEC Biotechnologies?: SiVEC Biotechnologies was founded by Lyndsey Linke, PhD in 2022.
How much funding has SiVEC Biotechnologies raised?: SiVEC Biotechnologies has disclosed $3.3M raised across 1 round.
Where is SiVEC Biotechnologies headquartered?: SiVEC Biotechnologies is headquartered in Fort Collins, US.